Premium
The effect of CYP2C19 polymorphism on the pharmacokinetics and acid‐inhibitory effects of oral lansoprazole and omeprazole
Author(s) -
BEKKERS C. H. J.,
TOUW D. J.,
LAMERS C. B. H. W.,
GEUS W. P.
Publication year - 2002
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1046/j.1365-2125.2002.t01-7-01714.x
Subject(s) - omeprazole , lansoprazole , cyp2c19 , pharmacokinetics , pharmacology , proton pump inhibitor , crossover study , gastric acid , cmax , chemistry , medicine , metabolism , cytochrome p450 , stomach , pathology , placebo , alternative medicine